Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 862.00 | |
50 mg | 6-8 weeks | $ 1,120.00 | |
100 mg | 6-8 weeks | $ 1,610.00 |
Description | MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition. |
Molecular Weight | 446.9 |
Formula | C21H19ClN2O5S |
CAS No. | 628300-71-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MLN3126 628300-71-0 inhibitor inhibit